ArticleJCI insight2026

Bispecific targeting of CHI3L1 and PD-1 as a therapeutic strategy for pulmonary fibrosis.

Han-Seok Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.